Generates large-scale, accredited deep multi-omic and linked clinical datasets from matched healthy tissue, cancer tissue and blood plus longitudinal population data. Applies AI/ML to discover biomarkers, predict treatment response, enable personalized oncology decision-making, and produce validated assets for therapeutic discovery and commercialization.